Anti-complement activity of clofibrinic acid. Research in vitro and in vivo
Di Perri, A.; Auteri, A.
Bollettino della Societa Italiana di Biologia Sperimentale 50(17): 1403-1408
1974
ISSN/ISBN: 0037-8771 PMID: 4477476 Document Number: 74318
Document emailed within 1 workday
Related Documents
Vos, G.H.; Armstrong, D.; Grobbelaar, B.G. 1971: Anti-red cell activity of lymphocytotoxic antibodies: an in vitro and in vivo evaluation South African Medical Journal 45(18): 487-491Kuchar, M. 1987: In vitro and in vivo activity of anti-inflammatory agents from the aspect of QSAR Ceskoslovenska Farmacie 36(4): 186-189
Walport, M.J. 1993: Inherited complement deficiency--clues to the physiological activity of complement in vivo Quarterly Journal of Medicine 86(6): 355-358
Khaduev, S.K.; Umanskiĭ, V.I.; Vesa, V.S.; Sinkaĭ, K.; Akedo, K.; Berezov, T.T. 1991: Anti-invasive and anti-metastatic effect of lysine oxidase from Trichoderma sp. in vitro and in vivo Biulleten' Eksperimental'noi Biologii i Meditsiny 112(10): 419-422
Giroud, J.P.; Timsit, J. 1970: Anti-complement and anti-inflammatory activity of 48-80 Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 164(11): 2119-2124
Ebbesen, P.; Olsson, L.; Rudkobing, O.; Haahr, S.; Kristensen, G. 1977: Correlation of in vivo cancer, net outer charge, in vitro migration, interferon activity, in vitro growth rates, and chalone-like activity to transformation-reversion in cloned Moloney and Kristen sarcoma virus-transformed mouse 3T3 cells Cancer Research 37(12): 4285-4290
Endo, N. 1988: In vitro and in vivo augmentation by muroctasin of the production of the third component of complement by murine macrophages Arzneimittel-Forschung 38(7a): 993-996
Petz, L.; Fudenberg, H.H.; Fink, D. 1971: Immune adherence reactions of human erythrocytes sensitized with complement in vitro and in vivo Journal of Immunology 107(6): 1714-1722
Morgan, B.P.; Daniels, R.H.; Watts, M.J.; Williams, B.D. 1988: In vivo and in vitro evidence of cell recovery from complement attack in rheumatoid synovium Clinical and Experimental Immunology 73(3): 467-472
Gathirwa, J.W.; Rukunga, G.M.; Njagi, E.N.M.; Omar, S.A.; Mwitari, P.G.; Guantai, A.N.; Tolo, F.M.; Kimani, C.W.; Muthaura, C.N.; Kirira, P.G.; Ndunda, T.N.; Amalemba, G.; Mungai, G.M.; Ndiege, I.O. 2008: The in vitro anti-plasmodial and in vivo anti-malarial efficacy of combinations of some medicinal plants used traditionally for treatment of malaria by the Meru community in Kenya Journal of Ethnopharmacology 115(2): 223-231
Jackman, A.L.; Taylor, G.A.; O'Connor, B.M.; Bishop, J.A.; Moran, R.G.; Calvert, A.H. 1990: Activity of the thymidylate synthase inhibitor 2-desamino-N10-propargyl-5,8-dideazafolic acid and related compounds in murine (L1210) and human (W1L2) systems in vitro and in L1210 in vivo Cancer Research 50(17): 5212-5218
Ferkany, J.W.; Slevin, J.T.; Zaczek, R.; Coyle, J.T. 1982: Failure of folic acid derivatives to mimic the actions of kainic acid in brain in vitro or in vivo Neurobehavioral Toxicology and Teratology 4(5): 573-579
Berthoux, F.X.; Freyria, A.M.; Traeger, J. 1977: Anticomplementary activity of a polyanion: pentosan-poly-sulfoester, II.--Mode of action and "in vitro " inhibition of human complement hemolytic activity Pathologie-Biologie 25(2): 105-108
Lechner, U.; Appel, K.R.; Werner, R.G. 1985: 6R-[(R)-2-[3-[2-(p-Aminosulfonyl)anilino-4-hydroxy-5- pyrimidinyl]ureido]-2-(4-hydroxyphenyl)acetamido]-penicillanic acid, sodium salt (VX-VC 43), a new broad-spectrum beta-lactam antibiotic. in vitro and in vivo antibiotic activity Arzneimittel-Forschung 35(1a): 351-355
Yokota, T.; Suzuki, E.; Arai, K. 1988: Cefpodoxime proxetil, its in vitro antibacterial activity, affinity to bacterial penicillin-binding proteins, and synergy of bactericidal activity with serum complement and mouse-cultured macrophages Drugs under Experimental and Clinical Research 14(8): 495-500
Fox, A.E. 1978: Standardization of the anti-complement activity in Coombs serum Minerva Medica 69(37): 2530-2534
Weiler, J.M.; Linhardt, R.J. 1991: Antithrombin III regulates complement activity in vitro Journal of Immunology 146(11): 3889-3894
Chimirri, A.; Grasso, S.; Montforte, A.M.; Monforte, P.; Zappalà, M. 1994: Anti-HIV agents. III. Synthesis and in vitro anti-HIV activity of novel 1H,3H-thiazolo[3,4-a]imidazo[4,5-b]pyridines Farmaco 49(5): 345-348
Chimirri, A.; Grasso, S.; Monforte, A.M.; Monforte, P.; Rao, A.; Zappalà, M.; Bruno, G.; Nicolò, F.; Scopelliti, R. 1997: Anti-HIV agents. V. Synthesis, structure and in vitro anti-HIV activity of novel 1H,3H-naphtho[2',3':4,5]imidazo[1,2-c]thiazoles Farmaco 52(11): 673-677
Lavrova, T.R.; Rodshteĭn, O.A.; Kositskaia, L.S.; Fridman, E.M.; Savel'vol'f, G.B. 1978: Anti-complement activity and blood serum cryoglobulins in rheumatoid arthritis Terapevticheskii Arkhiv 50(9): 68-72